• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经典结构可识别性方法在受体理论中应用于低维动态系统。

Classical structural identifiability methodology applied to low-dimensional dynamic systems in receptor theory.

机构信息

Swansea University, Swansea, UK.

Leiden University, Leiden, The Netherlands.

出版信息

J Pharmacokinet Pharmacodyn. 2024 Feb;51(1):39-63. doi: 10.1007/s10928-023-09870-y. Epub 2023 Jun 30.

DOI:10.1007/s10928-023-09870-y
PMID:37389744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10884104/
Abstract

Mathematical modelling has become a key tool in pharmacological analysis, towards understanding dynamics of cell signalling and quantifying ligand-receptor interactions. Ordinary differential equation (ODE) models in receptor theory may be used to parameterise such interactions using timecourse data, but attention needs to be paid to the theoretical identifiability of the parameters of interest. Identifiability analysis is an often overlooked step in many bio-modelling works. In this paper we introduce structural identifiability analysis (SIA) to the field of receptor theory by applying three classical SIA methods (transfer function, Taylor Series and similarity transformation) to ligand-receptor binding models of biological importance (single ligand and Motulsky-Mahan competition binding at monomers, and a recently presented model of a single ligand binding at receptor dimers). New results are obtained which indicate the identifiable parameters for a single timecourse for Motulsky-Mahan binding and dimerised receptor binding. Importantly, we further consider combinations of experiments which may be performed to overcome issues of non-identifiability, to ensure the practical applicability of the work. The three SIA methods are demonstrated through a tutorial-style approach, using detailed calculations, which show the methods to be tractable for the low-dimensional ODE models.

摘要

数学建模已成为药理学分析的关键工具,有助于理解细胞信号动力学和量化配体-受体相互作用。受体理论中的常微分方程 (ODE) 模型可用于使用时程数据参数化此类相互作用,但需要注意感兴趣参数的理论可识别性。可识别性分析是许多生物建模工作中经常被忽视的步骤。在本文中,我们通过将三种经典的 SIA 方法(传递函数、泰勒级数和相似变换)应用于具有生物学重要性的配体-受体结合模型(单配体和 Motulsky-Mahan 竞争结合单体,以及最近提出的单配体结合受体二聚体模型),将结构可识别性分析 (SIA) 引入受体理论领域。得到了新的结果,这些结果表明对于 Motulsky-Mahan 结合和二聚体化受体结合的单个时程可识别参数。重要的是,我们进一步考虑了可以执行的实验组合,以克服不可识别性问题,确保工作的实际适用性。通过使用详细计算的教程式方法演示了这三种 SIA 方法,表明这些方法对于低维 ODE 模型是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/f9f1f9c9f07a/10928_2023_9870_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/5df464414b0a/10928_2023_9870_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/a1efbb1c9b46/10928_2023_9870_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/86b5204d4a7c/10928_2023_9870_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/5a27bde1379f/10928_2023_9870_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/f9f1f9c9f07a/10928_2023_9870_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/5df464414b0a/10928_2023_9870_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/a1efbb1c9b46/10928_2023_9870_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/86b5204d4a7c/10928_2023_9870_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/5a27bde1379f/10928_2023_9870_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8a/10884104/f9f1f9c9f07a/10928_2023_9870_Fig5_HTML.jpg

相似文献

1
Classical structural identifiability methodology applied to low-dimensional dynamic systems in receptor theory.经典结构可识别性方法在受体理论中应用于低维动态系统。
J Pharmacokinet Pharmacodyn. 2024 Feb;51(1):39-63. doi: 10.1007/s10928-023-09870-y. Epub 2023 Jun 30.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Structural identifiability of linear-in-parameter parabolic PDEs through auxiliary elliptic operators.通过辅助椭圆算子研究参数线性抛物型偏微分方程的结构可识别性
J Math Biol. 2025 May 29;91(1):4. doi: 10.1007/s00285-025-02225-w.
8
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
9
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
Insights into the dynamics of ligand-induced dimerisation via mathematical modelling and analysis.通过数学建模与分析洞察配体诱导二聚化的动力学
J Theor Biol. 2022 Apr 7;538:110996. doi: 10.1016/j.jtbi.2021.110996. Epub 2022 Jan 24.
2
Testing structural identifiability by a simple scaling method.通过简单的缩放方法进行结构可识别性检验。
PLoS Comput Biol. 2020 Nov 3;16(11):e1008248. doi: 10.1371/journal.pcbi.1008248. eCollection 2020 Nov.
3
Exact solutions and equi-dosing regimen regions for multi-dose pharmacokinetics models with transit compartments.
具有时变隔室的多剂量药代动力学模型的精确解和等剂量方案区域。
J Pharmacokinet Pharmacodyn. 2021 Feb;48(1):99-131. doi: 10.1007/s10928-020-09719-8. Epub 2020 Oct 10.
4
An efficient procedure to assist in the re-parametrization of structurally unidentifiable models.一种有效的方法,用于辅助结构不可识别模型的重新参数化。
Math Biosci. 2020 May;323:108328. doi: 10.1016/j.mbs.2020.108328. Epub 2020 Mar 11.
5
Considerations for improved performance of competition association assays analysed with the Motulsky-Mahan's "kinetics of competitive binding" model.考虑使用 Motulsky-Mahan 的“竞争结合动力学”模型分析改进竞争结合分析的性能。
Br J Pharmacol. 2019 Dec;176(24):4731-4744. doi: 10.1111/bph.14841. Epub 2019 Dec 26.
6
Investigating the Influence of Tracer Kinetics on Competition-Kinetic Association Binding Assays: Identifying the Optimal Conditions for Assessing the Kinetics of Low-Affinity Compounds.探究示踪动力学对竞争动力学结合分析的影响:确定评估低亲和力化合物动力学的最佳条件。
Mol Pharmacol. 2019 Sep;96(3):378-392. doi: 10.1124/mol.119.116764. Epub 2019 Jul 10.
7
Kinetic operational models of agonism for G-protein-coupled receptors.G蛋白偶联受体激动作用的动力学操作模型
J Theor Biol. 2018 Jun 7;446:168-204. doi: 10.1016/j.jtbi.2018.02.014. Epub 2018 Feb 25.
8
Structural identifiability for mathematical pharmacology: models of myelosuppression.结构可识别性在数学药理学中的应用:骨髓抑制模型。
J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):79-90. doi: 10.1007/s10928-018-9569-x. Epub 2018 Feb 2.
9
Ligand Binding Dynamics for Pre-dimerised G Protein-Coupled Receptor Homodimers: Linear Models and Analytical Solutions.预二聚化 G 蛋白偶联受体同源二聚体的配体结合动力学:线性模型和解析解。
Bull Math Biol. 2019 Sep;81(9):3542-3574. doi: 10.1007/s11538-017-0387-x. Epub 2018 Jan 18.
10
Parameter Identifiability of Fundamental Pharmacodynamic Models.基本药效学模型的参数可识别性
Front Physiol. 2016 Dec 5;7:590. doi: 10.3389/fphys.2016.00590. eCollection 2016.